Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04196530
Title BDB001-102 Open Label Dose Escalation Combination w Atezolizumab
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Birdie Biopharmaceuticals HK Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Angeles Clinic Los Angeles California 90025 United States Details
Florida Cancer Specialists Sarasota Florida 34230 United States Details
Tennessee Oncology Nashville Tennessee 37203 United States Details
NEXT Oncology San Antonio Texas 78229 United States Details
South Texas Accelerated Research Therapeutics (START) San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field